What is Biosino Bio-Technology and Science Incorporation's (8247.HK) StockRank?

MoatMap's StockRank for Biosino Bio-Technology and Science Incorporation (8247.HK) is 23/100, with a Sell signal. This is a composite score combining Quality (20), Value (44), and Momentum (50) factor ranks across MoatMap's 20,000+ stock universe.

Does Biosino Bio-Technology and Science Incorporation have an economic moat?

Biosino Bio-Technology and Science Incorporation (8247.HK) has a Quality factor score of 20/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Biosino Bio-Technology and Science Incorporation a buy, hold, or sell?

MoatMap's current signal for Biosino Bio-Technology and Science Incorporation (8247.HK) is Sell, based on a StockRank of 23/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Biosino Bio-Technology and Science Incorporation in?

Biosino Bio-Technology and Science Incorporation (8247.HK) operates in the Healthcare sector, specifically the Diagnostics & Research industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

8247.HK

SELLREMOVE

Biosino Bio-Technology and Science Incorporation · Healthcare · China · $55M · Avg Vol: $17K/d

StockRank

P/E (TTM)

—

ROE

-45.2%

D/E

1.4x

Dividend %

—

Director Trades · 180d

+$15.2K →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Biosino Bio-Technology is a micro-cap diagnostics company with weak financial metrics and a low quality score. It lacks the scale, pricing power, and global distribution network to benefit from any major healthcare macro shifts.

COMPANY DESCRIPTION

Biosino Bio-Technology and Science Incorporation develops, manufactures, and distributes in-vitro diagnostic (IVD) reagents and instruments in China. Backed by its historical association with the Chinese Academy of Sciences, the company is a pioneer in the domestic diagnostic market. Its competitive moat is sustained by a comprehensive portfolio of clinical chemistry reagents and a well-established nationwide distribution network.

FINANCIAL SUMMARY (USD)

Year	2021	2022	2023	2024	2025	CAGR
Revenue	—	48M	37M	34M	24M	-20.9%
EPS	-0.00	0.01	-0.01	-0.04	—	—
Shares	—	145M	145M	145M	145M	0.0%
Debt	—	19M	19M	20M	21M	2.4%
Equity	—	26M	27M	21M	15M	-16.4%
Op CF	—	6M	-837,200	3M	-3M	-27.0%
Inv CF	—	-142,554	-2M	-2M	-580,170	—
Fin CF	—	-1M	1M	-899,863	735,103	—

PRICE (1M)-2.7%

SMA 50SMA 200

$0.36

RSI (14)

16.7

52W High

$0.89

From 52W High

0.4%

SCORE BREAKDOWN

Quality

ROIC

-47.7%15.0

ROE

-45.2%19.3

GP/Assets

20.2%47.1

Op. Margin

-40.2%22.4

FCF/Assets

-5.5%35.1

Piotroski

—0.8

Int. Cover

-8.9x25.8

D/E Ratio

1.44x9.2

Current Ratio

0.82x5.9

Value

P/E (TTM)

—N/A

EV/EBITDA

-11.9x83.1

P/FCF

—N/A

P/B

2.6x45.7

P/S

2.0x68.5

Div Yield

—N/A

Momentum

52W High %

41%13.0

RS 6M

41%92.3

SMA 50/200

1.15x85.6

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$55M

P/E (Forward)

—

Gross Margin

38.5%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 8247.HK are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
8247.HK	Biosino Bio-Technology and Science Incorporation(you)	$55M	23	SELL
BNR	Burning Rock Biotech Limited	$107M	5	STRONG SELL
9860.HK	Adicon Holdings Limited	$394M	32	SELL
603716.SS	Thalys Medical Technology Group Corporation	$568M	31	SELL
603108.SS	Shanghai Runda Medical Technology Co., Ltd.	$1.1B	21	SELL
2427.HK	Guanze Medical Information Industry (Holding) Co., Ltd.	$526M	42	HOLD
300463.SZ	Maccura Biotechnology Co.Ltd	$845M	33	SELL
9960.HK	Kindstar Globalgene Technology, Inc.	$139M	70	BUY
300676.SZ	BGI Genomics Co., Ltd.	$2.3B	37	HOLD
300347.SZ	Hangzhou Tigermed Consulting Co., Ltd	$5.0B	28	SELL

Peer medians: ROE 4.8% · P/E 27.8x · Gross margin 53.1%

Biosino Bio-Technology and Science Incorporation (8247.HK) — Stock Score Summary

Biosino Bio-Technology and Science Incorporation (8247.HK) has a MoatMap StockRank of 23/100 based on Quality (20/100), Value (44/100), and Momentum (50/100) factor scores. The current signal is SELL. Biosino Bio-Technology is a micro-cap diagnostics company with weak financial metrics and a low quality score. It lacks the scale, pricing power, and global distribution network to benefit from any major healthcare macro shifts.

Key Financial Metrics

Price	$0.36
Market Cap	$55M
Price/Book	2.58
Return on Equity	-45.2%
Return on Invested Capital	-47.7%
Debt/Equity	144.23
Gross Margin	38.5%
Operating Margin	-40.2%
Revenue Growth	-31.5%
Free Cash Flow	$-362K

Biosino Bio-Technology and Science Incorporation operates in the Diagnostics & Research industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Biosino Bio-Technology and Science Incorporation’s (8247.HK) StockRank?: MoatMap’s StockRank for Biosino Bio-Technology and Science Incorporation (8247.HK) is 23/100, with a Sell signal. It is a composite of Quality (20), Value (44), and Momentum (50) factor ranks across MoatMap’s 20,000+ stock universe.
Does Biosino Bio-Technology and Science Incorporation have an economic moat?: Biosino Bio-Technology and Science Incorporation (8247.HK) has a Quality factor score of 20/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Biosino Bio-Technology and Science Incorporation a buy, hold, or sell?: MoatMap’s current signal for Biosino Bio-Technology and Science Incorporation (8247.HK) is Sell, based on a StockRank of 23/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Biosino Bio-Technology and Science Incorporation in?: Biosino Bio-Technology and Science Incorporation (8247.HK) operates in the Healthcare sector, specifically the Diagnostics & Research industry (China).